<- Go Home
Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Market Cap
GBP 27.3M
Volume
622.8K
Cash and Equivalents
GBP 6.6M
EBITDA
GBP 1.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 9.7M
Profit Margin
69.58%
52 Week High
GBP 0.46
52 Week Low
GBP 0.07
Dividend
N/A
Price / Book Value
3.05
Price / Earnings
21.95
Price / Tangible Book Value
3.05
Enterprise Value
GBP 20.7M
Enterprise Value / EBITDA
15.19
Operating Income
GBP 1.2M
Return on Equity
17.91%
Return on Assets
6.12
Cash and Short Term Investments
GBP 6.6M
Debt
N/A
Equity
GBP 9.0M
Revenue
GBP 13.9M
Unlevered FCF
-GBP 2.6M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium